AMPH logo

AMPH
Amphastar Pharmaceuticals Inc

1,131
Mkt Cap
$969.11M
Volume
343,451.00
52W High
$31.26
52W Low
$17.03
PE Ratio
10.50
AMPH Fundamentals
Price
$21.38
Prev Close
$21.36
Open
$21.36
50D MA
$22.92
Beta
0.80
Avg. Volume
629,182.21
EPS (Annual)
$2.03
P/B
1.24
Rev/Employee
$364,315.28
$1,661.95
Loading...
Loading...
News
all
press releases
Amphastar Pharmaceuticals (NASDAQ:AMPH) Price Target Lowered to $23.00 at Barclays
Barclays reduced their target price on shares of Amphastar Pharmaceuticals from $30.00 to $23.00 and set an "equal weight" rating for the company in a report on Wednesday...
MarketBeat·6d ago
News Placeholder
More News
News Placeholder
Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Given Average Rating of "Hold" by Brokerages
Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH - Get Free Report) has been given an average recommendation of "Hold" by the eight ratings firms that are currently covering the stock, MarketBeat...
MarketBeat·7d ago
News Placeholder
SG Americas Securities LLC Makes New Investment in Amphastar Pharmaceuticals, Inc. $AMPH
SG Americas Securities LLC purchased a new stake in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH - Free Report) in the fourth quarter, according to the company in its most recent filing with the...
MarketBeat·11d ago
News Placeholder
Amphastar Pharmaceuticals (NASDAQ:AMPH) Share Price Passes Below Two Hundred Day Moving Average - Should You Sell?
Amphastar Pharmaceuticals (NASDAQ:AMPH) Stock Passes Below Two Hundred Day Moving Average - What's Next...
MarketBeat·14d ago
News Placeholder
Clark Capital Management Group Inc. Invests $7.56 Million in Amphastar Pharmaceuticals, Inc. $AMPH
Clark Capital Management Group Inc. purchased a new stake in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH - Free Report) in the third quarter, according to the company in its most recent filing with...
MarketBeat·30d ago
News Placeholder
Algert Global LLC Acquires 268,612 Shares of Amphastar Pharmaceuticals, Inc. $AMPH
Algert Global LLC raised its holdings in shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH - Free Report) by 216.1% during the third quarter, according to its most recent filing with the...
MarketBeat·30d ago
News Placeholder
Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Receives Average Rating of "Hold" from Analysts
Shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH - Get Free Report) have been given an average recommendation of "Hold" by the eight brokerages that are covering the firm, MarketBeat reports...
MarketBeat·1mo ago
News Placeholder
Amphastar Pharmaceuticals (NASDAQ:AMPH) Reaches New 12-Month Low - Should You Sell?
Amphastar Pharmaceuticals (NASDAQ:AMPH) Sets New 12-Month Low - Should You Sell...
MarketBeat·1mo ago
News Placeholder
Vanguard Group Inc. Has $70.12 Million Stock Position in Amphastar Pharmaceuticals, Inc. $AMPH
Vanguard Group Inc. reduced its position in shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH - Free Report) by 2.1% in the 3rd quarter, according to the company in its most recent filing with...
MarketBeat·1mo ago
News Placeholder
Amphastar Pharmaceuticals (NASDAQ:AMPH) Sets New 1-Year Low - Should You Sell?
Amphastar Pharmaceuticals (NASDAQ:AMPH) Hits New 1-Year Low - What's Next...
MarketBeat·1mo ago
<
1
2
...
>

Latest AMPH News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.